101 related articles for article (PubMed ID: 22123497)
1. The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.
Malfitano AM; Laezza C; Galgani M; Matarese G; D'Alessandro A; Gazzerro P; Bifulco M
Pharmacol Res; 2012 Mar; 65(3):365-71. PubMed ID: 22123497
[TBL] [Abstract][Full Text] [Related]
2. Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells.
Malfitano AM; Laezza C; Pisanti S; Gazzerro P; Bifulco M
Br J Pharmacol; 2008 Mar; 153(5):1003-10. PubMed ID: 18157162
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism.
Sarnataro D; Pisanti S; Santoro A; Gazzerro P; Malfitano AM; Laezza C; Bifulco M
Mol Pharmacol; 2006 Oct; 70(4):1298-306. PubMed ID: 16822929
[TBL] [Abstract][Full Text] [Related]
4. Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice.
Malfitano AM; Sosa S; Laezza C; De Bortoli M; Tubaro A; Bifulco M
Br J Pharmacol; 2011 Jan; 162(1):84-93. PubMed ID: 20880029
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.
Ciaglia E; Torelli G; Pisanti S; Picardi P; D'Alessandro A; Laezza C; Malfitano AM; Fiore D; Pagano Zottola AC; Proto MC; Catapano G; Gazzerro P; Bifulco M
Oncotarget; 2015 Jun; 6(17):15464-81. PubMed ID: 26008966
[TBL] [Abstract][Full Text] [Related]
6. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.
Jbilo O; Ravinet-Trillou C; Arnone M; Buisson I; Bribes E; Péleraux A; Pénarier G; Soubrié P; Le Fur G; Galiègue S; Casellas P
FASEB J; 2005 Sep; 19(11):1567-9. PubMed ID: 16009704
[TBL] [Abstract][Full Text] [Related]
7. Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon.
Santoro A; Pisanti S; Grimaldi C; Izzo AA; Borrelli F; Proto MC; Malfitano AM; Gazzerro P; Laezza C; Bifulco M
Int J Cancer; 2009 Sep; 125(5):996-1003. PubMed ID: 19479993
[TBL] [Abstract][Full Text] [Related]
8. Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages.
Miranville A; Herling AW; Biemer-Daub G; Voss MD
Obesity (Silver Spring); 2010 Dec; 18(12):2247-54. PubMed ID: 20379144
[TBL] [Abstract][Full Text] [Related]
9. Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents.
Croci T; Landi M; Galzin AM; Marini P
Br J Pharmacol; 2003 Sep; 140(1):115-22. PubMed ID: 12967941
[TBL] [Abstract][Full Text] [Related]
10. The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase.
Esposito I; Proto MC; Gazzerro P; Laezza C; Miele C; Alberobello AT; D'Esposito V; Beguinot F; Formisano P; Bifulco M
Mol Pharmacol; 2008 Dec; 74(6):1678-86. PubMed ID: 18801918
[TBL] [Abstract][Full Text] [Related]
11. Rimonabant inhibits proliferation, collagen secretion and induces apoptosis in hepatic stellate cells.
Dai E; Zhang J; Zhang D; Yang L; Wang Y; Jiang X; Ye L; Li X; Liu H; Ma J; Jiang H
Hepatogastroenterology; 2014 Oct; 61(135):2052-61. PubMed ID: 25713910
[TBL] [Abstract][Full Text] [Related]
12. Rimonabant-induced apoptosis in leukemia cell lines: activation of caspase-dependent and -independent pathways.
Gallotta D; Nigro P; Cotugno R; Gazzerro P; Bifulco M; Belisario MA
Biochem Pharmacol; 2010 Aug; 80(3):370-80. PubMed ID: 20417624
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin.
Gazzerro P; Malfitano AM; Proto MC; Santoro A; Pisanti S; Caruso MG; Notarnicola M; Messa C; Laezza C; Misso G; Caraglia M; Bifulco M
Oncol Rep; 2010 Jan; 23(1):171-5. PubMed ID: 19956878
[TBL] [Abstract][Full Text] [Related]
14. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice.
Ravinet Trillou C; Arnone M; Delgorge C; Gonalons N; Keane P; Maffrand JP; Soubrie P
Am J Physiol Regul Integr Comp Physiol; 2003 Feb; 284(2):R345-53. PubMed ID: 12399252
[TBL] [Abstract][Full Text] [Related]
15. Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve.
Costa B; Trovato AE; Colleoni M; Giagnoni G; Zarini E; Croci T
Pain; 2005 Jul; 116(1-2):52-61. PubMed ID: 15936882
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes.
Tedesco L; Valerio A; Cervino C; Cardile A; Pagano C; Vettor R; Pasquali R; Carruba MO; Marsicano G; Lutz B; Pagotto U; Nisoli E
Diabetes; 2008 Aug; 57(8):2028-36. PubMed ID: 18477809
[TBL] [Abstract][Full Text] [Related]
17. NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile.
Mastinu A; Pira M; Pani L; Pinna GA; Lazzari P
Behav Brain Res; 2012 Oct; 234(2):192-204. PubMed ID: 22771813
[TBL] [Abstract][Full Text] [Related]
18. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
[TBL] [Abstract][Full Text] [Related]
19. Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant.
Gerdeman GL; Schechter JB; French ED
Neuropsychopharmacology; 2008 Oct; 33(11):2747-59. PubMed ID: 18059436
[TBL] [Abstract][Full Text] [Related]
20. Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice.
Nam DH; Lee MH; Kim JE; Song HK; Kang YS; Lee JE; Kim HW; Cha JJ; Hyun YY; Kim SH; Han SY; Han KH; Han JY; Cha DR
Endocrinology; 2012 Mar; 153(3):1387-96. PubMed ID: 22234468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
